Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07644923 · ClinicalTrials.gov registry record · Phase 4
Postoperative Non-Opioid Pain Management Utilizing Local Anesthetics Coupled With Modulated Coagulation
A Phase 4 study, sponsored by NYU Langone Health.
- Not yet
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
NCT07644923 is a Phase 4 study that has not yet begun recruiting, run by NYU Langone Health. The registered enrollment target is 40 participants.
The verdict
NCT07644923, a Phase 4 study, has not yet begun recruiting, sponsored by NYU Langone Health.
- NOT YET RECRUITING
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
Study Summary
This study is a prospective randomized trial examining the effect of tranexamic acid (TXA) and aminocaproic acid (ε-Ahx) with local anesthetics and thrombin in all electively created surgical wound beds in hand surgery to provide long term pain relief and decrease the use of postoperative narcotics. All surgical created wounds for any hand surgery will be treated in a randomized fashion with the following four arms: 1. Bupivacaine + lidocaine 2. Bupivacaine + lidocaine + thrombin 3. Bupivacaine + lidocaine + thrombin + tranexamic acid 4. Bupivacaine + lidocaine + thrombin + aminocaproic acid All are applied topically to surgical bed prior to closure of skin.
Interventions
- DRUG Bupivacaine
- DRUG Lidocaine
- DRUG Tranexamic acid
- DRUG Aminocaproic acid
- DRUG Thrombin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2026-08-01 |
| Est. Completion | 2029-02-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07644923
The ClinicalTrials.gov registry entry for NCT07644923 describes a study currently listed as not yet recruiting, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Bupivacaine is the first listed.
NCT07644923 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07644923 about?
NCT07644923 is a clinical study titled "Postoperative Non-Opioid Pain Management Utilizing Local Anesthetics Coupled With Modulated Coagulation". This study is a prospective randomized trial examining the effect of tranexamic acid (TXA) and aminocaproic acid (ε-Ahx) with local anesthetics and thrombin in all electively created surgical wound beds in hand surgery to provide long term pain relief and decrease the use of postoperative narcotics....
What is the current status of trial NCT07644923?
This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2026-08-01. Estimated completion is 2029-02-01.
What interventions are being tested in trial NCT07644923?
The interventions under investigation include: Bupivacaine (DRUG), Lidocaine (DRUG), Tranexamic acid (DRUG), Aminocaproic acid (DRUG), Thrombin (DRUG).
Who is sponsoring clinical trial NCT07644923?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.